In 2008, François-Henri Boissel was leading a charmed life. He was a young, successful investment banker working in Tokyo, Japan. And then the market crashed.
He thought of sticking it out, waiting until things improved, but then he remembered a conversation he’d had with his father, Jean-Pierre, in the summer of 2007, and it started gnawing at him.
His father had had a long career in clinical research and had always dreamed of using mathematics to “find truly innovative therapies and dramatically improve patient outcomes,” François recalls. The pair had discussed the idea of using mathematical modeling to improve innovation in the pharmaceutical industry, but François had put that idea to the side because he was enjoying the banker’s life and the pharmaceutical industry seemed risky. But in 2008, things changed.
Click "source" to read more.